Yahoo Web Search

Search results

    • Q1 2024 Voyager Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 13 hours ago

      s potential to transform the treatment of CNS diseases. In addition to Neurocrine, our partners include Novartis and Alexion. In total, our partnered programs could generate up to $8.2 billion ...

    • Skirmish over paper drug info draws on

      Politico· 9 hours ago

      The organization took a $140 million final payment from Philip Morris International but has now pledged to not take funding from tobacco or nonmedicinal nicotine companies ...